Address
Rho Ventures
525 University Avenue
Suite 1350
Palo Alto, CA 94301
United States
Phone
Website
Recent investment activity
KANDO id: 31423
Corporate information
Founders
Also known as
Rho Ventures
Registration country
Company type
Venture capital firm that actively invests in companies related to technology, new media, cleaning technology and healthcare.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 126 - 150 of 216| Company | Profile | Country | Funding | ||
|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Dashlane SAS | N/A Initial investment | |||
|
|
Genetic Therapy Inc | N/A | |||
|
|
Vidyo Inc | Developer of components for video across IP networks. | N/A | ||
|
|
Mahi Networks Inc | N/A Initial investment | |||
|
|
Inotek Pharmaceuticals Corp | Inotek Pharmaceuticals is a clinical-stage ophthalmic pharmaceutical company. | N/A Initial investment | ||
|
|
Cellit Inc | Developer of software to automate multimedia customer interaction. | N/A Initial investment | ||
|
|
SiteStuff Inc | N/A | |||
|
|
Procept Inc | N/A | |||
|
|
Quovadx Inc | Provider of internet based software connects hospitals, government entities, and health plans. | N/A | ||
|
|
Xtera Communications Inc | N/A | |||
|
|
MIPS Computer Systems Inc | Supplier of RISC technology for the computer system and embedded control markets. | N/A | ||
|
Sensors for Medicine and Science | N/A | |||
|
|
PharmaGenics Inc | Developer of therapeutic products. | N/A | ||
|
|
Landmark Graphics Corp | N/A | |||
|
|
NitroMed Inc | Pharmaceutical company focused on the research, development, and commercialization of pharmaceuticals for cardiovascular and inflammatory diseases. | N/A | ||
|
|
NowPublic (NowPublic.com) | Crowdsourcing news network empowering the ordinary citizen. | N/A | ||
|
|
Oloop | N/A | |||
|
|
Optilink Corp | N/A | |||
|
|
Orqis Medical Corp | Develops and sells minimally invasive devices for improving cardiac performance through aortic flow therapy. | N/A | ||
|
|
Osteoarthritis Sciences Inc | Designs and develops therapies and pharmaceutical products for the treatment of arthritis. | N/A | ||
|
|
Meriton Networks Inc | N/A | |||
|
|
MediGene AG | Biotechnology company focused on the research and development of innovative drugs to treat cancer and autoimmune diseases. | N/A | ||
|
|
Main Control Inc | N/A | |||
|
|
Genaera Corp | A biopharmaceutical company, engages in the research and development of medicines to address the obesity, type 2 diabetes, and respiratory diseases. | N/A | ||
|
|
Lukens Medical Corp | N/A |